Loved Ones, Brain Disorders, Alzheimers, Dementia

As a patient you already know the techniques I use support brain health. The brain communicates with your body and the care you receive enhances your neurology.

But what happens when there is a disorder of the brain itself? One of the things we first notice is memory loss. Now, "remember" we must also take a look at the biochemistry of the body and....

There are exciting things happening in the area of brain research to help with disorders of the brain. I initially discovered this approach in 2010 but was still somewhat skeptical back then. 

I'm always reminding myself, "The frog in the well knows not of the great ocean beyond...but only sees the sky above."  This is certainly one of those seeing beyond items.

I have observed hundreds of studies on this topic and am excited to see the results evolving. Read on....

Photobiomodulation (PBM) describes the use of red or near-infrared light to stimulate, heal, regenerate, and protect tissue that has either been injured, is degenerating, or else is at risk of dying. Yes, please re-read that last sentence.

One of the organ systems of the human body that is most necessary to life, and whose optimum functioning is most worried about by humankind in general, is the brain.

The brain suffers from many different disorders that can be classified into three broad groupings: traumatic events (stroke, traumatic brain injury, and global ischemia), degenerative diseases (dementia, Alzheimer's and Parkinson's), and psychiatric disorders (depression, anxiety, post traumatic stress disorder).


There is some evidence that all these seemingly diverse conditions can be beneficially affected by applying light to the head.


There is even the possibility that PBM could be used for cognitive enhancement in normal healthy people.


In this transcranial PBM (tPBM) application, near-infrared (NIR) light is often applied to the forehead because of the better penetration (no hair, longer wavelength).


Some workers have used lasers, but recently the introduction of inexpensive light emitting diode (LED) arrays has allowed the development of light emitting helmets or “brain caps”.


This research review article will cover the mechanisms of action of photobiomodulation to the brain, and summarize some of the key pre-clinical studies and clinical trials that have been undertaken for diverse brain disorders.

To order and download a free copy of the research article click here: 
http://www.draristotle.com/store/p12/brain


Here's another research article surrounding Home Treatment For Dementia..

Significant Improvement in Cognition in Mild to Moderately Severe Dementia Cases Treated with Transcranial Plus Intranasal Photobiomodulation 
Aug 2017

Abstract
Objective: This study investigated whether patients with mild to moderately severe dementia or possible Alzheimer's Disease (AD) with Mini-Mental State Exam (MMSE) Baseline scores of 10–24 would improve when treated with near-infrared photobiomodulation (PBM) therapy.

Background: 
Animal studies have presented the potential of PBM for AD. Dysregulation of the brain's default mode network (DMN) has been associated with AD, presenting the DMN as an identifiable target for PBM.

Materials and Methods:
The study used 810 nm, 10 Hz pulsed, light-emitting diode devices combining transcranial plus intranasal PBM to treat the cortical nodes of the DMN (bilateral mesial prefrontal cortex, precuneus/posterior cingulate cortex, angular gyrus, and hippocampus).

Five patients with mild to moderately severe cognitive impairment were entered into 12 weeks of active treatment as well as a follow-up no-treatment, 4-week period. Patients were assessed with the MMSE and Alzheimer's Disease Assessment Scale (ADAS-cog) tests.

The protocol involved weekly, in-clinic use of a transcranial-intranasal PBM device; and daily at-home use of an intranasal-only device.

Results: 
There was significant improvement after 12 weeks of PBM (MMSE, p < 0.003; ADAS-cog, p < 0.023). Increased function, better sleep, fewer angry outbursts, less anxiety, and wandering were reported post-PBM.

There were no negative side effects.

Precipitous declines were observed during the follow-up no-treatment, 4-week period. This is the first completed PBM case series to report significant, cognitive improvement in mild to moderately severe dementia and possible AD cases.

Conclusions: 
Results suggest that larger, controlled studies are warranted. PBM shows potential for home treatment of patients with dementia and AD.

Ordering Tip
If you are interested in the intranasal light devices or have product inquiries please contact https://vielight.com and use office code HEAL to receive our professional order pricing.